article thumbnail

STAT’s most memorable photos of 2022

STAT

Reflecting back on our favorite photographs from 2022, we are struck by how many portraits were in our selection. These images also document a pipeline program for Indigenous medical students, an incarcerated person fighting for better hepatitis C care, and a trailblazing Alzheimer’s researcher.

article thumbnail

Dasami Labs-Walk-In Drive for Quality Control/ Production/ AQA / Production Documentation/ Engineering On 18th Sept’ 2022

Pharma Pathway

Dasami Labs-Walk-In Drive for Quality Control/ Production/ AQA / Production Documentation/ Engineering On 18th Sept’ 2022. Walk-In Drive for Quality Control/ Production/ AQA / Production Documentation/ Engineering On 18th Sept’ 2022 On 18th Sept’ 2022 @ Dasami Labs. Date : 18th Sept’ 2022. Job Description.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Hospital systems’ investment income perked up at end of 2022

STAT

Large hospital systems’ investments rebounded heavily in the final quarter of 2022, according to a new STAT analysis of financial filings. STAT analyzed the financial documents of 37 tax-exempt, not-for-profit health systems covering the last three months of 2022.

Hospitals 241
article thumbnail

STAT+: FTC says pharmacy benefit managers are stonewalling requests for information

STAT

antitrust regulators into pharmaceutical industry middlemen has been stymied because the companies have failed to provide many of the documents that, in some cases, were requested as far back as June 2022. A much-anticipated inquiry by U.S.

article thumbnail

UK ATMP clinical trials report 2022 published

European Pharmaceutical Review

The Cell and Gene Therapy (CGT) Catapult has published its ‘ UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 ’. The research observed this cell type took up 58 percent of UK ATMP clinical trials in 2022. . The number of Phase II/III trials increased from three trials in 2021 to seven trials in 2022.

article thumbnail

Zydus Lifesciences Limited-Walk-In Interviews for Production On 3rd Dec’ 2022

Pharma Pathway

Zydus Lifesciences Limited-Walk-In Interviews for Production On 3rd Dec’ 2022. Should have exposure to regulatory requirement of documentation. Desired Candidates Profile: •Candidates to have exposure in Pharmaceutical Company (API plant) and regulatory requirements of Documentation and cGMP/ GLP. Job Description.

article thumbnail

Intas Pharmaceuticals under FDA scrutiny after oversight in GMP documents

Pharmafile

India-based manufacturer Intas Pharmaceuticals has been issued a Form 483 by the FDA after three investigators found a “cascade of failure” in a site inspection carried out at their manufacturing facility in Pharmez Special Economic Zone (SEZ) between late November and early December 2022. read more